Yeast Infection Treatment Market Application with Global Industry Growth, Size, Demand, Trends, Insights and Forecast
The global yeast infection
market is well-established and is growing pervasively. Increasing prevalence of
the infection felled by the predominant risk factors such as widespread use of
antibiotics and possibly even global warming contribute to the growth of the
market. Moreover, factors such as well spread awareness towards this kind of
infection and the availability of novel medications and treatment procedures
are proving impetus to the market growth.
Acknowledging the kind of traction, the market perceives currently, Market
Research Future (MRFR) in its recently published study report anticipates that
the global yeast infection market will garner exponential accruals by 2023,
registering approximately 5.2 % CAGR during the forecast period (2017-2023).
Request Sample Copy:
https://www.marketresearchfuture.com/sample_request/4228
The genital area in women is prone to yeast infections. Yeast infections are a
result of fungus growth that reaches a finale of inflammation, blisters or
painful discharge. Certain health conditions resulting in recurrent infections
in women are pregnancy, disability, premenopausal, or postmenopausal,
immunocompromised patients with diabetes, or women who are taking estrogens
replacements are at an increased risk for recurrent vaginal yeast infections.
Improving economic conditions worldwide that enables access to the quality and
improved healthcare fuel the market growth. Additional factors propelling the market
growth include the changing or unhealthy lifestyle & pollution owing to the
growing urbanization & industrialization. Technological advancements in the
medical science backed by the substantial investments made in the R&D
activities foster the market growth of yeast infection treatments excellently,
bringing about innovative treatments and medicines.
Global Yeast Infection Market - Segments
Global Yeast Infection Treatment Market Application is segmented into five Key dynamics for an easy grasp
and enhanced understanding.
By Pathogens : Candida Albicans, Candida Glabrata, and Candida Rugosa, among
others.
By Types : Skin Yeast Infection, Vaginal Yeast Infection, and Throat Yeast
Infection, among others.
By Treatments : Drug Treatments (cream, ointment, tablet, and suppository.),
and Surgery among others.
By End-Users : Hospital, Clinics, and Ambulatory Centers among others.
By Regions : Europe, North America, APAC and Rest of the World.
Global Yeast Infection Market - Regional
analysis
The North America region accounts for the largest market share in the global
yeast infection market followed by the Europe & Asia Pacific regions,
respectively. The yeast infection market in North America is growing due to the
significant contribution from the significantly increasing market for the U.S.
due to the increasing number of patients suffering from immune diseases and
presence of huge geriatric population.
The Asia Pacific region is
rapidly emerging as a lucrative market for the yeast infection. Countries such
as China and India backed by the huge population and the low-cost medications
and procedures available to treat the yeast infection foster the market growth
in the region. Moreover, the rapidly growing healthcare sector coupled with the
large unmet needs over the forecast period will provide impetus to the market
growth.
Global Yeast Infection Market - Competitive
Analysis
The global yeast infection market is a fragmented market with a large number of
players. Increasing cases of drug resistance have opened doors for new drug
development and opportunities for a new market leader. The increase of spurious
and counterfeit medicines have reduced the total market revenues and at the
same time displaced standard drugs off the market.
Key Players:
Some of the eminent leaders fostering the global yeast infection market include
Synmedic Laboratories (India), Scynexis (US), Merck & Co., Inc. (US), Bayer
AG (Germany), Astellas (Japan), Mentis Pharma Ltd. (India), Novartis AG
(Switzerland), Abbott (US), Pfizer Inc. (US), ALLERGAN (Ireland), Sanofi
(France), and AstraZeneca (UK).
Access Report @
https://www.marketresearchfuture.com/reports/yeast-infection-market-4228
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact:
Akash Anand
Market Research Future
+1 646 845 9312
Comments
Post a Comment